Clinical Trial Update: Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection [Phase 3]

View source ↗

Summary

Phase 3 trial in pediatric patients compares tenofovir disoproxil fumarate to placebo for chronic hepatitis B; results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2018-09-19